Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial

Sube Banerjee; Juliet High; Susan Stirling; Lee Shepstone; Ann Marie Swart; Tanya Telling; Catherine Henderson; Clive Ballard; Peter Bentham; Alistair Burns; Nicolas Farina; Chris Fox; Paul Francis; Robert Howard; Martin Knapp; Iracema Leroi; Gill Livingston; Ramin Nilforooshan; Shirley Nurock; John O'Brien; Annabel Price; Alan J. Thomas; Naji Tabet

doi:10.1016/s0140-6736(21)01210-1

Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial

Sube Banerjee^*, Juliet High, Susan Stirling, Lee Shepstone, Ann Marie Swart, Tanya Telling, Catherine Henderson, Clive Ballard, Peter Bentham, Alistair Burns, Nicolas Farina, Chris Fox, Paul Francis, Robert Howard, Martin Knapp, Iracema Leroi, Gill Livingston, Ramin Nilforooshan, Shirley Nurock, John O'BrienAnnabel Price, Alan J. Thomas, Naji Tabet

^*Corresponding author for this work

Peninsula Medical School

Research output: Contribution to journal › Article › peer-review

9 Downloads (Pure)

Original language	English
Pages (from-to)	1487-1497
Number of pages	0
Journal	The Lancet
Volume	398
Issue number	10310
Early online date	21 Oct 2021
DOIs	https://doi.org/10.1016/s0140-6736(21)01210-1
Publication status	Published - 21 Oct 2021

Access to Document

10.1016/s0140-6736(21)01210-1

PIIS0140673621012101

Cite this

Banerjee, S., High, J., Stirling, S., Shepstone, L., Swart, A. M., Telling, T., Henderson, C., Ballard, C., Bentham, P., Burns, A., Farina, N., Fox, C., Francis, P., Howard, R., Knapp, M., Leroi, I., Livingston, G., Nilforooshan, R., Nurock, S., ... Tabet, N. (2021). Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial. The Lancet, 398(10310), 1487-1497. https://doi.org/10.1016/s0140-6736(21)01210-1

@article{bb597b4c37d945a89e06feab570f35ab,

title = "Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial",

author = "Sube Banerjee and Juliet High and Susan Stirling and Lee Shepstone and Swart, {Ann Marie} and Tanya Telling and Catherine Henderson and Clive Ballard and Peter Bentham and Alistair Burns and Nicolas Farina and Chris Fox and Paul Francis and Robert Howard and Martin Knapp and Iracema Leroi and Gill Livingston and Ramin Nilforooshan and Shirley Nurock and John O'Brien and Annabel Price and Thomas, {Alan J.} and Naji Tabet",

year = "2021",

month = oct,

day = "21",

doi = "10.1016/s0140-6736(21)01210-1",

language = "English",

volume = "398",

pages = "1487--1497",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

number = "10310",

}

Banerjee, S, High, J, Stirling, S, Shepstone, L, Swart, AM, Telling, T, Henderson, C, Ballard, C, Bentham, P, Burns, A, Farina, N, Fox, C, Francis, P, Howard, R, Knapp, M, Leroi, I, Livingston, G, Nilforooshan, R, Nurock, S, O'Brien, J, Price, A, Thomas, AJ & Tabet, N 2021, 'Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial', The Lancet, vol. 398, no. 10310, pp. 1487-1497. https://doi.org/10.1016/s0140-6736(21)01210-1

TY - JOUR

T1 - Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial

AU - Banerjee, Sube

AU - High, Juliet

AU - Stirling, Susan

AU - Shepstone, Lee

AU - Swart, Ann Marie

AU - Telling, Tanya

AU - Henderson, Catherine

AU - Ballard, Clive

AU - Bentham, Peter

AU - Burns, Alistair

AU - Farina, Nicolas

AU - Fox, Chris

AU - Francis, Paul

AU - Howard, Robert

AU - Knapp, Martin

AU - Leroi, Iracema

AU - Livingston, Gill

AU - Nilforooshan, Ramin

AU - Nurock, Shirley

AU - O'Brien, John

AU - Price, Annabel

AU - Thomas, Alan J.

AU - Tabet, Naji

PY - 2021/10/21

Y1 - 2021/10/21

U2 - 10.1016/s0140-6736(21)01210-1

DO - 10.1016/s0140-6736(21)01210-1

M3 - Article

SN - 0140-6736

VL - 398

SP - 1487

EP - 1497

JO - The Lancet

JF - The Lancet

IS - 10310

ER -